metformin has been researched along with Failed Back Surgery Syndrome in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Failed Back Surgery Syndrome: A condition of persistent pain and discomfort in the BACK and the LEG following lumbar surgery, often seen in patients enrolled in pain centers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Z | 1 |
| Wu, T | 1 |
| Sun, J | 1 |
| Wang, H | 1 |
| Hua, F | 1 |
| Nicolas, YSM | 1 |
| Kc, R | 1 |
| Chen, K | 1 |
| Jin, Z | 1 |
| Liu, J | 1 |
| Zhang, M | 1 |
1 other study available for metformin and Failed Back Surgery Syndrome
| Article | Year |
|---|---|
Metformin attenuates post-epidural fibrosis by inhibiting the TGF-β1/Smad3 and HMGB1/TLR4 signaling pathways.
Topics: Animals; Failed Back Surgery Syndrome; Fibrosis; HMGB1 Protein; Humans; Male; Metformin; Mice; Mice, | 2021 |